4410 studies found for:    "Diabetes Mellitus, Type 2"
Show Display Options
Rank Status Study
1 Completed Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: GSK716155 for injection
2 Completed Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Conditions: Obesity;   Diabetes Mellitus, Type 2;   Abnormal Glucose Metabolism;   Type 2 Diabetes
Intervention: Behavioral: Assignment of a Lay Patient Partner
3 Completed Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions: Drug: GSK189075 oral tablets;   Drug: metformin tablets
4 Completed A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: Rosiglitazone 4 mg
5 Completed Study Of AVANDAMET With Or Without Insulin In Type II Diabetes Mellitus Patients
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: Rosiglitazone/metformin
6 Active, not recruiting Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions: Biological: albiglutide;   Drug: sitagliptin;   Drug: glimepiride;   Drug: metformin
7 Completed In-patient Study in Patients With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: exenatide
8 Terminated A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions: Drug: Insulin;   Drug: Oral GW677954 Capsules (15 mg)
9 Completed In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: GSK716155 subcutaneous injections;   Biological: placebo injection
10 Completed A Study of MK3102 in Obese Subjects and in Patients With Type 2 Diabetes (3102-004)
Condition: Type 2 Diabetes (T2D)
Interventions: Drug: MK3102;   Drug: Comparator: Placebo
11 Completed Study In People With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: GW677954
12 Terminated Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus
Conditions: Hyperlipidemia;   Diabetes Mellitus, Type 2;   Non-Insulin Dependent Diabetes Mellitus
Interventions: Drug: Atorvastatin;   Drug: Placebo
13 Withdrawn A Study in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2608204;   Drug: Glimepiride
14 Not yet recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
15 Completed Plant-Based Dietary Intervention in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Low-fat, low-Glycemic Index, vegan diet
16 Active, not recruiting Immune Profile and Complication Risk in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention:
17 Completed
Has Results
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin;   Drug: Alogliptin Placebo;   Drug: Metformin Placebo
18 Completed Exercise Training in Patients With Coronary Heart Disease and Type 2 Diabetes
Conditions: Coronary Artery Disease;   Diabetes Mellitus, Type 2;   Atherosclerosis
Intervention: Behavioral: Exercise
19 Completed Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: nitroprusside, pentalong, imdur, AICAR, isoptin
20 Completed An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: CKD-501 0.5mg;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years